Biotech, Clinical Research, Pharmaceutical News & Jobs

BioSpace Login

Enter your BioSpace account email address and password to log in now.

Email Address

Password

Keep me logged in

Close Window

Forgot Your Password? | Privacy Statement

NEW MEMBER SIGN UP

Display Name

Email Address

Password

Password again

Zip

Country

Close Window

Privacy Statement

Biotech and Pharmaceutical
News & Jobs

Search the Site

Community Login

What is this?

Employers
Post Job | Search Resumes | Login

NEWSLETTERS
Free Newsletters
Archive
My eNewsletters

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

COMMUNITY
Login
Become a Member
Discussion Forums
FAQ

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

BIOTECH WORK PORTAL
Career Definitions
Labor Market Reports
Education & Training
Regions

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
BioPharm Insight

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

Friday, July 30, 2010

Sanofi-Aventis (France) (SASY.PA) Board Said to Support Genzyme Corporation (GENZ) Bid of Up to $18.7 Billion More...

FDA Advisory Committee Recommends Approval of AstraZeneca PLC (AZN)'s Brilinta (Ticagrelor) for Acute Coronary Syndromes; AstraZeneca Lifts Forecast Due to Ruling More...

Shionogi Inc. Announces FDA Approval of CUVPOSA for the Treatment of Chronic Severe Drooling in Pediatric Patients With Neurologic Conditions More...

Abbott Laboratories (ABT)'s SIMCOR(R) (Niacin Extended-Release/Simvastatin ) Receives FDA Approval for New Dosage Strengths More...

Allergan Inc. (AGN) Eye Drug Wins EU OK For Fluid Buildup More...

Omeros Corporation Secures $40 Million Committed Equity Financing Facility More...

Aptuit, Inc. and Siena Biotech S.p.A. Announce Strategic Relationship in Italy; Siena Takes Minor Slice of Aptuit's Italian R&D Operations More...

Isis Pharmaceuticals, Inc. (ISIS) Earns $5 Million Milestone Payment From GlaxoSmithKline (GSK) for Designation of a Development Candidate to Treat an Undisclosed Rare and Serious Disease More...

Market Summary

Symbol Lookup

BioPharm Executive: Firing Slows, but Lilly Fans the Flames More...

Astellas Pharma Inc. (YPH.BE) to Pay $295 Million to Extend License of Regeneron Pharmaceuticals, Inc. (REGN)'s VelocImmune(R) Antibody Technology Through 2023 More...

Trius Therapeutics Set to go Public This Week More...

Pfizer Inc. (PFE)'s Viagra Weighed by U.S. FDA for Children With Rare Lung Disorder More...

Allos Therapeutics, Inc. (ALTH)'s Cancer Drug, Folotyn Extends Lung Cancer Survival More...

GlaxoSmithKline (GSK) to Change Way it Pays U.S. Drug Sales Reps More...

Illumina, Inc. (ILMN) Acquires Helixis, Inc. for Up to $105M, To Get Small, Low-Cost Genetic Analysis Tool More...

Tris Pharma, Inc. Announces Approval of First-Time Generic of Methylphenidate Hydrochloride Oral Solution With Six Months Exclusivity More...

Alcohol Reduces the Severity of Rheumatoid Arthritis, University of Sheffield Study Finds More...

AstraZeneca PLC (AZN) Bloodthinner, Brilinta Goes Before U.S. Experts Today More...





		Advanced Search

FDA Considering Changes To Risky Drug Safeguards More...

BioNJ Study: Biotech Employment Grew Despite Downturn More...

Patients 'Could Grow New Joints', Columbia University, University of Missouri And Clemson University Study More...

Leap Forward In Efforts To Develop Treatments For Huntington's Disease, Buck Institute for Age Research Study More...

Super-Sizing A Cancer Drug Minimizes Side Effects, Harvard University And Massachusetts Institute of Technology (MIT) Study More...

Breaching the Blood-Brain Barrier To Create Powerful New Tools for Fighting Cancer, Rensselaer Polytechnic Institute Study More...

Alzheimer's Unlocked: New Keys To A Cure More...

An HPV Vaccine Cheap Enough for the Developing World? Could Be According to Duke University Researchers More...

Nitto Denko Technical Corporation	Senior Biologist
Nitto Denko Technical Corporation	Oligonucleotide Group: Senior Scientist
Crown Biosciences	Head of Cancer Drug Plate Based Pharmacology Group
Stanford University	Biodesign Innovation Fellowship
Memorial Sloan-Kettering Cancer Center	Scientific Research Director

Vertex Pharmaceuticals is a global biotechnology company committed to the discovery and development of breakthrough small molecule drugs for serious diseases. The Company’s strategy is to commercialize its products both independently and in collaboration with major pharmaceutical companies. Vertex’s product pipeline is focused on viral diseases, inflammation, autoimmune diseases, cancer, pain, cystic fibrosis and bacterial infection. Vertex co-discovered the HIV protease inhibitor, Lexiva, with GlaxoSmithKline.
View Vertex's latest job posting: Senior Regulatory Operations Associate

Show me jobs for this employer

You're the Perfect Fit, So Why Did the Hiring Manager Say, "No"? More...

Addressing Salary Requirements in a Cover Letter More...

Smart Tips for Getting a Job: A Better Approach More...

Five Tips for Acing a Phone Interview More...

Tips to Make Your Job Interview a Success More...

Don't Be a Perfectionist in Your Job Search More...

Poll: How Much Is Beauty Worth at Work? More...

Smart Employers and Smart Job Applicants Seek the Same Thing More...

Seven Ways Not to Use Your Connections to Get a Job More...

Top Tips for Job Hunters: Successfully Field Interview Questions to Get the Job More...